or Try an Advanced Search...

    Technical Analysis for KAPA - Kairos Pharma, Ltd.

    Grade Last Price % Change Price Change
    F 1.34 2.29% 0.03
    KAPA closed up 2.29 percent on Friday, November 1, 2024, on 1 percent of normal volume. The stock exhibited some range contraction during this trading session as price made an NR7 -- narrowest range of the last seven sessions. Due to the stock's strong downtrend, it may remain oversold for a while. So, if you're looking for a reason to buy, don't put too much weight on it being oversold.
    0 Watchers
    Watchlist Portfolio

    Trend Table & Recent EOD Trading Signals

    ADX Long Term Intermediate Term Short Term
    Very Strong N/A N/A Down
    Historical KAPA trend table...
    Date Alert Name Type % Chg
    NR7 Range Contraction 0.00%
    Narrow Range Bar Range Contraction 0.00%
    Inside Day Range Contraction 0.00%
    Oversold Stochastic Weakness 0.00%
    20 DMA Resistance Bearish 2.29%
    Outside Day Range Expansion 2.29%
    Lower Bollinger Band Touch Weakness 2.29%
    Oversold Stochastic Weakness 2.29%
    20 DMA Resistance Bearish -0.74%
    Stochastic Reached Oversold Weakness -0.74%
    Older End-of-Day Signals for KAPA ...

       Recent Intraday Alerts

    Alert Time
    Down 5% 1 day ago
    Lower Bollinger Band Support 1 day ago
    60 Minute Opening Range Breakdown 1 day ago
    Outside Day 1 day ago
    Down 3% 1 day ago
    View Earlier Intraday Alerts

    Free Daily (Stock) Chart Reading

    Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
    Get Started for Free!
    Configure default chart indicators
    KAPA Chart by TradingView
    Basic chart:

    Profile

    • Earnings date: Unknown
    Kairos Pharma Ltd. is a clinical-stage biopharmaceutical company, which engages in the development of novel and transformative drug therapies to treat cancer. It focuses on the research and development of immunotherapies for oncology. The company was founded by John S. Yu on June 17, 2013 and is headquartered in Los Angeles, CA.
    Classification
    Sector: Healthcare
    Industry: Biotechnology
    Keywords: Biopharmaceutical Cancer Immunotherapies Drug Therapies

    Is KAPA a Buy, Sell or Hold?

    Indicator Bull Case Neutral / Hold Bear Case
    50 DMA
    200 DMA
    ADX Trend
    Oversold / Overbought
    Relative Strength
    Counts: 0 bullish, 2 bearish and 3 neutral indicators. You may wish to incorporate that into your trading strategies.

    Recent News

    Date Title
    Oct 22 Kairos Pharma to Present at the LD Micro Main Event XVII
    Oct 9 Kairos Pharma to Participate in a Fireside Chat at the 2024 Maxim Healthcare Virtual Summit
    Sep 17 Kairos Pharma Closing of $6.2 Million Initial Public Offering
    Sep 16 Kairos Pharma prices $6.2M IPO
    Sep 16 Kairos Pharma Prices $6.2 Million Initial Public Offering
    Sep 9 IPO Roundup: Bicara Therapeutics, Kairos Pharma and more
    See more KAPA news...

    Comments

    View full discussion...

    Indicators

    Indicator Value
    52 Week High 4.0
    52 Week Low 1.24
    Average Volume 88,448
    200-Day Moving Average 0.00
    50-Day Moving Average 0.00
    20-Day Moving Average 1.44
    10-Day Moving Average 1.41
    Average True Range 0.18
    RSI (14) 29.08
    ADX 53.23
    +DI 9.33
    -DI 22.47
    Chandelier Exit (Long, 3 ATRs) 1.14
    Chandelier Exit (Short, 3 ATRs) 1.79
    Upper Bollinger Bands 1.58
    Lower Bollinger Band 1.29
    Percent B (%b) 0.17
    BandWidth 20.45
    MACD Line -0.13
    MACD Signal Line -0.14
    MACD Histogram 0.0106
    Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
    Resistance 4 (R4) 1.37
    Resistance 3 (R3) 1.37 1.36 1.37
    Resistance 2 (R2) 1.36 1.35 1.36 1.37
    Resistance 1 (R1) 1.35 1.34 1.35 1.35 1.37
    Pivot Point 1.33 1.33 1.33 1.33 1.33
    Support 1 (S1) 1.32 1.32 1.33 1.33 1.31
    Support 2 (S2) 1.31 1.32 1.31 1.31
    Support 3 (S3) 1.30 1.31 1.31
    Support 4 (S4) 1.31